NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Beijing Wuhe Boao Pharmaceutical Co., Ltd.

Beijing Wuhe Boao Pharmaceutical Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttp://wehandbio.com/

Last Round

Series B

Extension

Sep 1, 2025

Est. Valuation

$562.09M

Total Funding Raised

$216.56M

Company Overview

Beijing Wuhe Boao Pharmaceutical Co., Ltd. is a biopharmaceutical company that develops natural drug innovations and advanced drug delivery systems for the treatment of metabolic disorders, malignant tumors, and inflammatory-immune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologynatural drugtype 2 diabetessangzhi alkaloidsSZ-Adrug developmentmetabolic disorderspharmaceutical manufacturingherbal medicinedrug delivery systemsmulti-target therapybioactive extractpharma R&Dnatural medicineclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beijing Wuhe Boao Pharmaceutical Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Beijing Wuhe Boao Pharmaceutical Co., Ltd. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Beijing Wuhe Boao Pharmaceutical Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionSep 1, 2025
Series CNov 4, 2024
Series BDec 24, 2020
Series ASep 1, 2015
Series A ExtensionJun 1, 2015

Beijing Wuhe Boao Pharmaceutical Co., Ltd. Investors

Notable investors and investment history

Beijing Wuhe Boao Pharmaceutical Co., Ltd. investors
InvestorRounds
Cathay CapitalSeries B, Series B Extension
Northern Light Venture CapitalSeries B Extension, Series A Extension
Lang Sheng InvestmentSeries B Extension
Cowin CapitalSeries B Extension, Series A Extension

Beijing Wuhe Boao Pharmaceutical Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Beijing Wuhe Boao Pharmaceutical Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Beijing Wuhe Boao Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range11
Year Founded2010
Last FundingSep 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.